Long-Term Safety and Efficacy of Risankizumab in Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Crohn's & Colitis
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients With Crohn's Disease: Results From the Phase 2 Open-Label Extension Study
J Crohns Colitis 2021 Jun 02;[EPub Ahead of Print], M Ferrante, BG Feagan, J Panés, F Baert, E Louis, O Dewit, A Kaser, WR Duan, Y Pang, WJ Lee, D Gustafson, X Liao, K Wallace, J Kalabic, GR D'HaensFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.